These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 14989296)

  • 1. [Place and significance of proton pump inhibitors in current treatment of peptic ulcers].
    Maev IV
    Eksp Klin Gastroenterol; 2003; (3):12-13. PubMed ID: 14989296
    [No Abstract]   [Full Text] [Related]  

  • 2. Alternative dosing for PPI therapy: rationale and options.
    Johnson DA
    Rev Gastroenterol Disord; 2003; 3 Suppl 4():S10-5. PubMed ID: 14671509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [ Treatment of peptic ulcers with proton pump inhibitors].
    Holtermüller KH
    Pharm Unserer Zeit; 2005; 34(3):206-9. PubMed ID: 15940953
    [No Abstract]   [Full Text] [Related]  

  • 4. Acid-related disorders and use of antisecretory medication.
    Lassen AT
    Dan Med Bull; 2007 Feb; 54(1):18-30. PubMed ID: 17349216
    [No Abstract]   [Full Text] [Related]  

  • 5. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proton pump inhibitors as the basis of anti-helicobacter therapeutic schemes].
    Isakov VA
    Eksp Klin Gastroenterol; 2004; (3):40-4. PubMed ID: 15560400
    [No Abstract]   [Full Text] [Related]  

  • 7. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
    Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
    Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A gastroenterologist's choice: proton pump inhibitors of H2 histamine receptor blockers in the treatment of peptic ulcer].
    Morozov IA
    Klin Med (Mosk); 2001; 79(5):68-71. PubMed ID: 11510196
    [No Abstract]   [Full Text] [Related]  

  • 9. [Proton pump inhibitor in ulcer disease?].
    Secknus R; Mössner J
    Internist (Berl); 1999 Mar; 40(3):325-6. PubMed ID: 10205762
    [No Abstract]   [Full Text] [Related]  

  • 10. Proton-pump inhibitor for peptic ulcer bleeding.
    Zullo A; Hassan C; Morini S
    Aliment Pharmacol Ther; 2005 Nov; 22(9):891-2; author reply 892. PubMed ID: 16225502
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial.
    O'Connell MB; Madden DM; Murray AM; Heaney RP; Kerzner LJ
    Am J Med; 2005 Jul; 118(7):778-81. PubMed ID: 15989913
    [No Abstract]   [Full Text] [Related]  

  • 12. Proton pump inhibitors and the risk of colorectal cancer: a meta-analysis.
    Chen S; Song X; Gao X; Li M; Chen Z; He Y; Zhan W
    J Clin Gastroenterol; 2011 Feb; 45(2):177. PubMed ID: 20697292
    [No Abstract]   [Full Text] [Related]  

  • 13. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
    Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention and treatment of gastroduodenal hemorrhages in pediatric cardiac surgery].
    Khar'kin AV; Lobacheva GV; Manerova AF; Abramian MA; Savchenko MV
    Anesteziol Reanimatol; 2005; (1):38-41. PubMed ID: 15839223
    [No Abstract]   [Full Text] [Related]  

  • 15. Proton pump inhibitor formulary considerations in the acutely ill. Part 2: Clinical efficacy, safety, and economics.
    Devlin JW; Welage LS; Olsen KM
    Ann Pharmacother; 2005 Nov; 39(11):1844-51. PubMed ID: 16204393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in proton pump inhibitors and management of acid-peptic disorders.
    Jain KS; Shah AK; Bariwal J; Shelke SM; Kale AP; Jagtap JR; Bhosale AV
    Bioorg Med Chem; 2007 Feb; 15(3):1181-205. PubMed ID: 17150362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is the successful eradication of Helicobacter pylori sufficient for the healing of peptic ulcer?].
    Pregun I; Herszényi L; Juhász M; Miheller P; Tulassay Z
    Orv Hetil; 2006 Mar; 147(10):435-9. PubMed ID: 16573172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: the pharmacodynamics and pharmacokinetics of proton pump inhibitors--overview and clinical implications.
    Robinson M
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():1-10. PubMed ID: 15496213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reflux esophagitis: healed! Now what?
    Romero Y; Egan LJ; Murray JA
    Am J Gastroenterol; 2000 Feb; 95(2):337-8. PubMed ID: 10685730
    [No Abstract]   [Full Text] [Related]  

  • 20. Proton pump inhibitors.
    Barry A
    Ir Med J; 1994; 87(5):134. PubMed ID: 7960649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.